PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pôle Pharmacie, Service Hospitalo-Universitaire de Pharmacie, CHU de Rennes, Rennes, France.\', \'Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé environnement et travail) - UMR_S 1085, Rennes, France.\', \'Laboratoire de Biopharmacie et Pharmacie Clinique, Faculté de Pharmacie, Université de Rennes 1, Rennes, France.\', \'Department of Psychiatry, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium.\', \'Research Unit (ULB 266), Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/jcpt.13390
?:hasPublicationType
?:journal
  • Journal of clinical pharmacy and therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 33645763
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.722
?:rankingScore_hIndex
  • 61
?:title
  • Repurposing functional inhibitors of acid sphingomyelinase (fiasmas): an opportunity against SARS-CoV-2 infection?
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33645763>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33645763>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all